Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Lambert

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of actionRahul Ray, James R Lambert
Current Urology Reports|September 4, 2008
Growth factors in benign prostatic hyperplasia: basic science implicationsM Scott Lucia, James R Lambert
Molecular Endocrinology (Baltimore, Md.)|March 15, 2003
CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestinsJames R Lambert, Steven K Nordeen
Neurobiology of Disease|July 4, 2008
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's diseasePaula A Desplats, James R Lambert, Elizabeth A Thomas
Molecular Cancer Research : MCR|November 5, 2010
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genesSunshine Daddario Axlund, James R Lambert, Steven K Nordeen
Cancer Letters|December 23, 2008
p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanismsJulie A Kelly, M Scott Lucia, James R Lambert
Journal of Cellular Biochemistry|January 3, 2013
Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2)Ramon J Whitson, Marshall Scott Lucia, James R Lambert
Biochemical and Biophysical Research Communications|July 31, 2007
Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cellsJames R Lambert, Christian D Young, Kelly S Persons, et al.
Biochemical Pharmacology|September 4, 2007
The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathwayVanessa Soto-Cerrato, Francesc Viñals, James R Lambert, et al.
Molecular Cancer Therapeutics|January 24, 2007
Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3beta activity in human breast cancer cellsVanessa Soto-Cerrato, Francesc Viñals, James R Lambert, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of actionRahul Ray, James R Lambert
Current Urology Reports|September 4, 2008
Growth factors in benign prostatic hyperplasia: basic science implicationsM Scott Lucia, James R Lambert
Molecular Endocrinology (Baltimore, Md.)|March 15, 2003
CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestinsJames R Lambert, Steven K Nordeen
Neurobiology of Disease|July 4, 2008
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's diseasePaula A Desplats, James R Lambert, Elizabeth A Thomas
Molecular Cancer Research : MCR|November 5, 2010
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genesSunshine Daddario Axlund, James R Lambert, Steven K Nordeen
Cancer Letters|December 23, 2008
p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanismsJulie A Kelly, M Scott Lucia, James R Lambert
Journal of Cellular Biochemistry|January 3, 2013
Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2)Ramon J Whitson, Marshall Scott Lucia, James R Lambert
Biochemical and Biophysical Research Communications|July 31, 2007
Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cellsJames R Lambert, Christian D Young, Kelly S Persons, et al.
Biochemical Pharmacology|September 4, 2007
The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathwayVanessa Soto-Cerrato, Francesc Viñals, James R Lambert, et al.
Molecular Cancer Therapeutics|January 24, 2007
Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3beta activity in human breast cancer cellsVanessa Soto-Cerrato, Francesc Viñals, James R Lambert, et al.
Pageof 4